^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    OncoSELECT

    Company:
    OncoDNA
    Type:
    Laboratory Developed Test
    Related tests:

    Details

    Evidence
    News
    OncoSELECT is a fast and minimally invasive analysis of circulating tumor DNA from a blood sample for lung (NSCLC), colorectal and breast (HR+ or HER2+) cancer patients. It is the perfect solution to identify therapeutic options for cancer patients not able to have their tumor biopsied or whose biopsy is too old. It can be used as a tool to detect treatment resistance to targeted therapies (before first-line to check the heterogeneity of the disease, or during/after treatment to check for acquired resistance mutations), as well as for monitoring cancer progression.
    Cancer:
    Breast Cancer, Colorectal Cancer, Non Small Cell Lung Cancer
    Gene:
    ER (Estrogen receptor), HER-2 (Human epidermal growth factor receptor 2), PGR (Progesterone receptor)
    Method:
    Circulating Tumor DNA (ctDNA)